跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ADAKVEO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ADAKVEO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Approved
STANDARD
ADAKVEO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Novartis Europharm Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Jan 31, 2021
Approval ID
23ddd8e17801aa11
Company
Novartis Europharm Limited
Type
Standard
Approval Details
Approval Id
23ddd8e17801aa11
Drug Cima Aemps Name
ADAKVEO 10 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number
1201476001
Holder Company Name
Novartis Europharm Limited
Marketing Company Name
Novartis Farmaceutica S.A.
Holder Company Detail Path
/organization/novartis-europharm-limited
Authorization Date
2021-01-31
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
10 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Novartis Europharm Limited
Company Detail Path
/organization/novartis-europharm-limited
Company Information
Pharmaceutical Company Name
NOVARTIS EUROPHARM LIMITED
Country Name
United Kingdom
City Name
camberley,country_gb
Address
200 Frimley Business Park
Active Ingredients
CRIZANLIZUMAB
100 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Jan 31, 2021
Approval ID
23ddd8e17801aa11
Type
Standard
Back to CIMA-AEMPS Approvals